Navigation Links
SenesTech Announces New Vice President of Business Development
Date:7/1/2009

FLAGSTAFF, Ariz., July 1 /PRNewswire/ -- SenesTech, Inc., a biotechnology corporation working on innovations for humane animal population management, announced the appointment of George M. Siegel as Vice President of Business Development.

Siegel has over 35 years of business development experience in executive management positions. He has served as Chairman of the Board of Directors for BrightStar Information Technology Group, Inc., Director of ILINC Communications, Inc., and President for RideAmerica Transportation Group, Parcelway Couriers Systems, Inc., Dynamex, and U.S. Messenger Service of Chicago, San Francisco.

"George's experience will be a valuable asset as he takes us to the world stage," said Everett Hale, CEO.

"I am excited to be part of SenesTech. I am enamored by the technology, which is so compelling, with the opportunity for growth and with the people. Loretta's (Dr. Loretta Mayer, Ph.D., Chief Scientific Officer and Chairman of the Board) knowledge is outstanding," George Siegel stated.

"As active Chairman of BrightStar, I worked in Southeast Asia and Australia," Siegel added. SenesTech plans to market their initial product, ContraPest to the agricultural ministries of Southeast Asia. Currently being field tested in Indonesia, ContraPest will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population.

"Our private investors will be very pleased with George's expertise in taking us public," stated Hale from SenesTech's world headquarters in Flagstaff, AZ.

About George M. Siegel

George Siegel has over 35 years of management experience in founding and managing public companies. His broad expertise focused on business development and mergers and acquisitions includes founding and co-founding four public companies in the transportation and technology sectors.

About SenesTech, Inc.

SenesTech is a platform biotechnology company located on the Northern Arizona Center for Emerging Technology campus in Flagstaff, Arizona. SenesTech specializes in humane animal population management products for wildlife and companion animals. For more information about SenesTech's biotech innovations for chemical fertility management visit http://www.senestech.com.


'/>"/>
SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SenesTech Scientists Attend International Workshop on Fertility in New Zealand
2. SenesTech, Inc. Appoints Susan Airhart to Board of Directors
3. SenesTech, Inc. Commences Product Registration Process With Australian Government
4. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
5. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2009 Results
7. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
8. Bion Announces Approval of New U.S. Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes
9. Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UKs Veterinary Laboratories Agency
10. Insmed Announces Addition to the Russell 3000(R) Index
11. BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
(Date:3/22/2017)... TORONTO , March 22, 2017 /PRNewswire/ - ... Therapeutics (the "Company" or "Propellon"), a start-up created ... WDR5-targeted anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive ... lead program. The seed funding enables Propellon to ... position the Company for financing and/or entering a ...
(Date:3/22/2017)... ... 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL will be the ... “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ ... and Therapy Act, Okyanos maintains a mission to help “no-option” patients and those ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant kiosk ... At PTE 2017 ... Materna will present its complete end-to-end passenger journey, from ... benefit for passengers. To accelerate the whole passenger handling process, ... to take passengers through the complete integrated process with a ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):